Benefits of Metformin in Attenuating the Hallmarks of Aging

By Ameya Sadguru Kulkarni, Sriram Gubbi, Nir Barzilai. Cell Metabolism, 2020

641 citations recorded by the source corpus.

SUMMARY Biological aging involves an interplay of conserved and targetable molecular mechanisms, summarized as the hallmarks of aging. Metformin- a biguanide that combats age-related disorders and improves healthspan, is the first drug to be tested for its age-targeting effects in the large clinical trial- TAME (Targeting Aging by MEtformin). This review focuses on metformin’s mechanisms in attenuating hallmarks of aging and their interconnectivity, by improving nutrient-sensing, enhancing autophagy and intercellular communication, protecting against macromolecular damage, delaying stem-cell aging, modulating mitochondrial function, regulating transcription, and lowering telomere attrition and senescence. These characteristics make metformin an attractive gerotherapeutic to translate to human trials.

Subfields: Molecular Biology, Neurology, Physiology

View Paper: https://www.semanticscholar.org/paper/8e49e4db85b0f5e33017ab171114e9fa35d5eb96

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

  1. Jesús Gil
  2. Jodie Birch

In Physiology

  1. Jesús Gil
  2. Jodie Birch

Citations in the corpus